CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 6 enrolled
Drug / intervention
Hypertonic saline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03276494
NCT03276494Phase 2Completed
CompareCT.gov

Intraosseous Administration of Hypertonic Saline in Acute Brain-injured Patients: A Prospective Case Series and Literature Review

Ohio State University·interventional·Posted Sep 8, 2017·Updated Jul 9, 2019

In Brief

A Phase 2 clinical trial evaluating Intraosseous and Hypertonic saline for Stroke and 2 related conditions. Completed, enrolled 6 participants across 1 site.

Detailed Summary

Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Intracranial Hypotension, Cerebral Edema
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedSep 8, 2017
Enrollment StartApr 21, 2017
Primary CompletionApr 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.8 years ago

Interventions

Intraosseousdevice

Intraosseous administration of hypertonic saline

Hypertonic salinedrug

Intraosseous administration of hypertonic saline